Skip to main content
SpringerLink
Log in

Metabolism of Ethanol and Some Associated Adverse Effects on the Liver and the Stomach

  • Chapter
Recent Developments in Alcoholism

Part of the book series: Recent Developments in Alcoholism ((RDIA,volume 14))

Abstract

Current knowledge of alcohol oxidation and its effects on hepatic metabolism and its toxicity are summarized. This includes an evaluation of the relationship of the level of consumption to its interaction with nutrients (especially retinoids, carotenoids, and folate) and the development of various stages of liver disease. Ethanol metabolism in the stomach and its link to pathology and Helicobacter pylori is reviewed. Promising therapeutic approaches evolving from newly gained insight in the pathogenesis of medical complications of alcoholism are outlined. At present, the established approach for the prevention and treatment of alcoholic liver injury is to control alcohol abuse, with the judicial application of selective antioxidant therapy, instituted at early stages, prior to the social or medical disintegration of the patient, and associated with antiinflammatory agents at the acute phase of alcoholic hepatitis. In addition, effective antifibrotic therapy may soon become available.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chedid A, Mendenhall CL, Gartside P, et al: Prognostic factors in alcoholic liver disease. AmJGastroenterol 86:210–216, 1991.

    CAS  Google Scholar 

  2. Lieber CS, Leo MA: Alcohol and the liver, in CS Lieber (ed): Medical and Nutritional Complications of Alcoholism: Mechanisms and Management. New York, Plenum Press, 1992, pp 185–240.

    Google Scholar 

  3. Lieber CS: Alcohol and the liver: 1994 Update. Gastroenterology 106:1085–1105, 1994.

    PubMed  CAS  Google Scholar 

  4. Lieber CS: Medical disorders of alcoholism. N EnglJ Med 333:1058–1065, 1995.

    CAS  Google Scholar 

  5. Lieber CS: Hepatic and other medical disorders of alcoholism: From pathogenesis to treatment. J Stud Alcohol 59:9–25, 1998.

    PubMed  CAS  Google Scholar 

  6. Faller J, Fox IH: Evidence for increased urate production by activation of adenine nucleotideturnover. N EnglJ Med 307:1598–1602, 1982.

    CAS  Google Scholar 

  7. Teschke R, Wiese B: Sex-dependency of hepatic alcohol metabolizing enzymes. J Endocrinol Invest 5:243–250, 1982.

    PubMed  CAS  Google Scholar 

  8. Maly PI, Sasse D: Intra-acinar profiles of alcohol dehydrogenase and aldehyde dehy-drogenase activities in human liver. Gastroenterology 101:1716–1723, 1991.

    PubMed  CAS  Google Scholar 

  9. Zorzano A, Herrera E: In vivo ethanol elimination in man, monkey and rat: A lack of relationship between the ethanol metabolism and the hepatic activities of alcohol and aldehyde dehydrogenases. Life Sci 46:223–230, 1990.

    Article  PubMed  CAS  Google Scholar 

  10. Hernandez-Mudoz R, Caballeria J, Baraona E, et al: Human gastric alcohol dehydrogenase: Its inhibition by H2-receptor antagonists, and its effect on the bioavailability of ethanol. Alcoholism: Clin ExpRes 14:949–950, 1990.

    Google Scholar 

  11. Baraona E, Yokoyama A, Ishii H, et al: Lack of alcohol dehydrogenase isoenzyme activities in the stomach of Japanese subjects. Life Sci 49:1929–2934, 1991.

    Article  PubMed  CAS  Google Scholar 

  12. Moreno A, Parés X: Purification and characterization of a new alcohol dehydrogenase from human stomach. JBiochem 266:1128–1133, 1991.

    CAS  Google Scholar 

  13. Satre MA, Zgombic-Knight M, Duester G: The complete structure of human class IV alcohol dehydrogenase (retinol dehydrogenase) determined from the ADH 7 gene. J Biol Chem 269:15605–15612, 1994.

    Google Scholar 

  14. Yokoyarna H, Baraona E, Lieber CS Molecular cloning of human class IV alcohol dehy drogenase. Biochem Biophys Res Commun 203:219–224, 1994.

    Google Scholar 

  15. Yokoyama H, Baraona E, Lieber CS: Molecular cloning and chromosomal localization of ADH7 gene encoding human class IV ADH. Genomics 31:243–245, 1996.

    Article  PubMed  CAS  Google Scholar 

  16. Haber PS, Gentry T, Mak KM, et al: Metabolism of alcohol by human gastric cells: Relation to first-pass metabolism. Gastroenterology 111:863–870, 1996.

    Article  PubMed  CAS  Google Scholar 

  17. Frezza M, Di Padova C, Pozzato G, et al: High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 322:95–99, 1990.

    Article  PubMed  CAS  Google Scholar 

  18. DiPadova C, Worner TM, Julkunen RJK, et al: Effects of fasting and chronic alcohol con sumption on the first pass metabolism of ethanol. Gastroenterology 92:1169–1173, 1987.

    PubMed  CAS  Google Scholar 

  19. Roine RP, Gentry RT, Hernández-Muñoz R, et al: Aspirin increases blood alcohol concentrations in human after ingestion of ethanol. JAMA 264:2406–2408, 1990.

    PubMed  CAS  Google Scholar 

  20. Caballeria J, Baraona E, Rodamilans M, et al: Effects of cimetidine on gastric alcohol dehydrogenase activity and blood ethanol levels. Gastroenterology 96:388–392, 1989.

    PubMed  CAS  Google Scholar 

  21. Di Padova C, Roine R, Frezza M, et al: Effects of ranitidine on blood alcohol levels afterethanol ingestion: Comparison with other H2-receptor antagonists. JAMA 267:83–86, 1992.

    Google Scholar 

  22. Caballeria J, Baraona E, Deulofeu R, et al: Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity. Dig Dis Sci 36:1673–1679, 1991.

    PubMed  CAS  Google Scholar 

  23. Palmer RH, Frank WO, Nambi P, et al: Effects of various concomitant medications on gastric alcohol dehydrogenase and first pass metabolism of ethanol. Am J Gastroenterol 86:1749–1755, 1991.

    PubMed  CAS  Google Scholar 

  24. Seitz HK, Simanowski UA, Egerer G, et al: Human gastric alcohol dehydrogenase: In vitro characteristics and effect of cimetidine. Digestion 51:80–85, 1992.

    PubMed  CAS  Google Scholar 

  25. Mirmiran-Yazdy SA, Haber PS, Korsten MA, et al: Metabolism of ethanol in rat gastric cells and in inhibition by cimetidine. Gastroenterology 108:737–742, 1995.

    PubMed  CAS  Google Scholar 

  26. Hernández-Muñoz R, Caballeria J, Baraona E, et al: Human gastric alcohol dehydrogenase: Its inhibition by H2-receptor antagonists, and its effect on the bioavailability of ethanol. Alcohol Clin Exp Res 14:946–950, 1990.

    PubMed  Google Scholar 

  27. Fraser AG, Hudson M, Sawyerr AM, et al: Short report: The effect of ranitidine on postprandial absorption of a low dose of alcohol. Aliment Pharmacol Ther 6:267–271, 1992.

    PubMed  CAS  Google Scholar 

  28. Gupta AM, Baraona E, Lieber CS: Significant increase of blood alcohol by cimetidine after repetitive drinking of small alcohol doses. Alcohol Clin Exp Res 19:1083–1087, 1995.

    PubMed  CAS  Google Scholar 

  29. Seitz HK, Veith S, Czygan P, et al: In vivo interactions between H2-receptor antagonists and ethanol metabolism in man and in rats. Hepatology 4:1231–1234, 1984.

    PubMed  CAS  Google Scholar 

  30. Guram M, Howden CW, Holt S: Further evidence for an interaction between alcohol and certain H2-receptor antagonists. Alcohol Clin Exp Res 15:1084–1085, 1991.

    PubMed  CAS  Google Scholar 

  31. Sharma R, Gentry RT, Lim RT, et al: First pass metabolism of alcohol: Absence of diurnal variation and its inhibition by cimetidine after an evening meal. Dig Dis Sci 40:2091–2097, 1995.

    PubMed  CAS  Google Scholar 

  32. Feely J, Wood AJ: Effect of cimetidine on the elimination and actions of ethanol. JAMA 247:2819–2821, 1982.

    Article  PubMed  CAS  Google Scholar 

  33. Raufman JP, Notar-Francesco V, Raffaniello RD, et al: Histamine,-receptor antagonists do not alter serum ethanol levels in fed, nonalcoholic men. Ann Intern Med 118:488–494, 1993.

    PubMed  CAS  Google Scholar 

  34. Roine RP, Gentry RT, Lim Jr RT, et al: Effect of concentration of ingested ethanol on blood alcohol levels. Alcohol Clin Exp Res 15:734–738, 1991.

    PubMed  CAS  Google Scholar 

  35. Seitz HK, Egerer G, Simanowski UA, et al: Human gastric alcohol dehydrogenase activity: Effect of age, gender and alcoholism. Gut 34:1433–1437, 1993.

    PubMed  CAS  Google Scholar 

  36. Nutrition and Your Health: Dietary Guidelines for Americans. Washington, DC, US Department of Agriculture, US Department of Health and Human Services, Home and Garden Bulletin No. 232, 3rd ed, 1990.

    Google Scholar 

  37. Wald A, Van Thiel DH, Hoechstetter L: Effect of pregnancy on gastrointestinal transit. Dig Dis Sci 27:1015–1018, 1982.

    Article  PubMed  CAS  Google Scholar 

  38. Arora S, Baraona E, Lieber CS: Ranitidine increases blood alcohol levels in social drinkers. Gastroenterology 112:1214, 1997.

    Google Scholar 

  39. Feinman L, Korsten MA, Lieber CS: Alcohol and the digestive tract, in Lieber CS (ed): Medical and Nutritional Complications of Alcoholism: Mechanisms and Management, New York, Plenum Press, 1992, pp 307–340.

    Google Scholar 

  40. Pateron D, Fabre M, Ink O, et al: Influence de I’alcool et de la cirrhose sur la présence de Helicobacter pylori dans la muqueuse gastrique. Gastroenterol Clin Biol 14:555–568, 1990.

    PubMed  CAS  Google Scholar 

  41. Salmela KS, Salaspuro M, Gentry RT, et al: Helicobacter infection and gastric ethanol metabolism. Alcohol Clin Exp Res 18:1294–1299, 1994.

    PubMed  CAS  Google Scholar 

  42. Roine RP, Salmela KS, Salaspuro M: Alcohol metabolism in Helicobacter pylori-infected stomach. Ann Med 27:583–588, 1995.

    Article  PubMed  CAS  Google Scholar 

  43. Uppal R, Lateef SK, Korsten MA, et al: Chronic alcoholic gastritis: Roles of alcohol and Helicobacter pylori. Arch Intern Med 151:760–764, 1991.

    Article  PubMed  CAS  Google Scholar 

  44. Lieber CS, DeCarli LM: Ethanol oxidation by hepatic microsomes: Adaptive increase after ethanol feeding. Science 162:917–918, 1968.

    PubMed  CAS  Google Scholar 

  45. Lieber CS, DeCarli LM: Hepatic microsomal ethanol oxidizing system: In vitro characteristics and adaptive properties in vivo. J Biol Chem 245:2505–2512, 1970.

    PubMed  CAS  Google Scholar 

  46. Tsutsumi M, Lasker JM, Shimizu M, et al: The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology 10:437–446, 1989.

    PubMed  CAS  Google Scholar 

  47. Takahashi T, Lasker JM, Rosman AS, et al: Induction of P4502E1 in human liver by ethanol is due to a corresponding increase in encoding mRNA. Hepatology 17:236–245, 1993.

    PubMed  CAS  Google Scholar 

  48. Tsyrlov IB, Salmela KS, Kessova IG, et al: Effect of combined ethanol and 3-methyl-cholanthrene treatment on hepatic microsomal P4502E1 and P4501A2 in rats. Alcohol Clin Exp Res 10:A37, 1996.

    Google Scholar 

  49. Shimizu M, Lasker JM, Tsutsumi M, et al: Immunohistochemical localization of ethanolinducible P450IIE1 in the rat alimentary tract. Gastroenterology 99:1044–1053, 1990.

    PubMed  CAS  Google Scholar 

  50. Koivisto T, Mishin VM, Mak KM, et al: Induction of cytochrome P-4502E1 by ethanol in rat Kupffer cells. Alcohol Clin Exp Res 20:207–212, 1996.

    PubMed  CAS  Google Scholar 

  51. Lieber CS: Interactions of alcohol noncardiovascular medications, in Wassef M, Zakhari S (eds).: Alcohol and the Cardiovascular System, NIAAA Research Monograph No. 31, NIH-NIAAA Publication No. 96-4133, Washington, DC, US Government Printing Office, Superintendent of Documents, 1996, pp 679–712.

    Google Scholar 

  52. Hetu C, Joly J-G: Differences in the duration of the enhancement of liver mixed function oxidase activities in ethanol-fed rats after withdrawal. Biochern Pharmacol 34:1211–1216,1985.

    CAS  Google Scholar 

  53. Borowsky SA, Lieber CS: Interaction of methadone and ethanol metabolism. J Pharmacol Exp Ther 207:123–129, 978.

    Google Scholar 

  54. Hetu C, Dumont A, Joly JG: Effect of chronic ethanol administration on bromobenzene liver toxicity in the rat. Tox Appl Pharm 67:166–167, 1983.

    CAS  Google Scholar 

  55. Siegers CP, Heidbuchel K, Younes M: Influence of alcohol, dithiocarb and (+)-catechin on the hepatotoxicity and metabolism of vinylidene chloride in rats. J Appl Toxicol 3:90–95, 1983.

    PubMed  CAS  Google Scholar 

  56. Tsutsumi R, Leo MA, Kim C, et al: Interaction of ethanol with enflurane metabolism and toxicity: Role of P450IIE1. Alcohol Clin Exp Res 14:174–179, 1990.

    PubMed  CAS  Google Scholar 

  57. Kharasch ED, Thummel KE: Identification of cytochrome P4502E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology 79:795–897, 1993.

    PubMed  CAS  Google Scholar 

  58. Takagi T, Ishii H, Takahashi H, et al: Potentiation of halothane hepatotoxicity by chronic ethanol administration in rat: An animal model of halothane hepatitis. Pharmacol Biochem Behav 18:(Suppl 1) 461–465, 1983.

    PubMed  CAS  Google Scholar 

  59. Beskid M, Bialck J, Dzieniszewski J, et al: Effect of combined phenylbutazone and ethanol administration on rat liver. Exp Pathol 18:487–491, 1980.

    CAS  Google Scholar 

  60. Raucy JL, Lasker JM, Lieber CS, et al: Acetaminophen activation by human liver cyto-chromes P450IIE1 and P4501A2. Arch Biochem Biophys 271:283–273,1989.

    Article  Google Scholar 

  61. Black M: Acetaminophen hepatotoxicity. Ann Rev Med 35:577–593, 1984.

    Article  PubMed  CAS  Google Scholar 

  62. Seef LB, Cuccherini BA, Zimmerman HJ, et al: Acetaminophen hepatotoxicity in alcoholics. (Clinical review). Ann Intern Med 104:399–404, 1986.

    Google Scholar 

  63. Sato C, Matsuda Y, Lieber CS: Increased hepatotoxicity of acetaminophen after chronic ethanol consumption in the rat. Gastroenterology 80:140–148, 1981.

    PubMed  CAS  Google Scholar 

  64. Whitecomb DC, Block GD: Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 272:1845–1850, 1994.

    Google Scholar 

  65. Hirano T, Kaplowitz N, Tsukamoto H, et al: Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats. Hepatology 6:1423–1427, 1992.

    Google Scholar 

  66. Leo MA, Rosman A, Lieber CS: Differential depletion of carotenoids and tocopherol in liver diseases. Hepatology 17:977–986, 1993.

    Article  PubMed  CAS  Google Scholar 

  67. Dicker E, Cederbaum AI: Increased oxygen radical-dependent inactivation of metabolic enzymes by liver microsomes after chronic ethanol consumption. FASEB J 2:2901–2906, 1988.

    PubMed  CAS  Google Scholar 

  68. Lieber CS, Casini A, DeCarli LM, et al: S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology 11:165–172, 1990.

    PubMed  CAS  Google Scholar 

  69. Lieber CS, Garro A, Leo MA, et al: Alcohol and cancer. Hepatology 6:1005–1019, 1986.

    PubMed  CAS  Google Scholar 

  70. Leo MA, Lieber CS: Hepatic vitamin A depletion in alcoholic liver injury. N Engl J Med 307:597–601, 1982.

    Article  PubMed  CAS  Google Scholar 

  71. Sato M, Lieber CS: Hepatic vitamin A depletion after chronic ethanol consumption in baboons and rats. J Nutr 111:2015–2023, 1981.

    PubMed  CAS  Google Scholar 

  72. Leo MA, Kim CI, Lieber CS: NAD+-dependent retinol dehydrogenase in liver microsomes. Arch Biochem Biophys 259:241–249, 1987.

    Article  PubMed  CAS  Google Scholar 

  73. Leo MA, Lieber CS: New pathway for retinol metabolism in liver microsomes. JBiochem 260:5228–5231, 1985.

    CAS  Google Scholar 

  74. Leo MA, Lieber CS: Hypervitaminosis A: A liver lover’s lament. Hepatology 8:412–417, 1988.

    PubMed  CAS  Google Scholar 

  75. Leo MA, Arai M, Sato M, et al: Hepatotoxicity of vitamin A and ethanol in the rat. Gastroenterology 82:194–205, 1982.

    PubMed  CAS  Google Scholar 

  76. Leo MA, Lieber CS: Hepatic fibrosis after long-term administration of ethanol and moderate vitamin A supplementation in the rat. Hepatology 2:1–11, 1983.

    Google Scholar 

  77. Keitin D, Hartree EF: Properties of catalase: Catalysis of coupled oxidation of alcohols. Biochem J 39:293–301, 1945.

    Google Scholar 

  78. Sies H, Chance B: The steady state level of catalase compound I in isolated hemoglobin-free perfused rat liver. FEBS Lett 11:172–176, 1970.

    Article  PubMed  CAS  Google Scholar 

  79. Oshino N, Chance B, Sies H, et al: The role of H2O2 generation in perfused rat liver and the reaction of catalase compound I and hydrogen donors. Arch Biochem Biophys 154:117–131, 1973.

    Article  PubMed  CAS  Google Scholar 

  80. Handler JA, Thurman RG: Fatty acid-dependent ethanol metabolism. Biochem Biophys Res Commun 133:44–51, 1985.

    Article  PubMed  CAS  Google Scholar 

  81. Williamson JR, Scholz R, Browning ET, et al: Metabolic effects of ethanol in perfused rat liver. JBiol Chem 25:5044–5054, 1969.

    Google Scholar 

  82. Handler JA, Thurman RG: Redox interactions between catalase and alcohol dehydrogenase pathways of ethanol metabolism in the perfused rat liver. J Biol Chem 265:1510–1515, 1990.

    PubMed  CAS  Google Scholar 

  83. Inatomi N, Kato S, Ito D, et al: Role of peroxisomal fatty acid beta-oxidation in ethanol metabolism. Biochem Biophys Res Commun 163:418–423, 1989.

    Article  PubMed  CAS  Google Scholar 

  84. Takagi T, Alderman J, Geller J, et al: Assessment of the role of non-ADH ethanol oxidation in vivo and in hepatocytes from deermice. Biochem Pharmacal 35:3601–3606, 1986.

    CAS  Google Scholar 

  85. Kato S, Alderman J, Lieber CS: Respective roles of the microsomal ethanol oxidizing system (MEOS) and catalase in ethanol metabolism by deermice lacking alcohol dehydrogenase. Arch Biochem Biophys 254:586–591, 1987.

    Article  PubMed  CAS  Google Scholar 

  86. Kato S, Alderman J, Lieber CS: Ethanol metabolism in alcohol dehydrogenase deficient deermice is mediated by the microsomal ethanol oxidizing system, not by catalase. Alcohol Alcohol Suppl 1:231–234, 1987.

    PubMed  CAS  Google Scholar 

  87. Thurman RG, Brentzel HJ: The role of alcohol dehydrogenase in microsomal ethanol oxidation and the adaptive increase in ethanol metabolism due to chronic treatment with ethanol. Alcohol Clin Exp Res 1:33–38, 1977.

    PubMed  CAS  Google Scholar 

  88. Teschke R, Matsuzaki S, Ohnishi K, et al: Microsomal ethanol oxidizing system (MEOS): Current status of its characterization and its role. Alcohol Clin Exp Res 1:7–15, 1977.

    PubMed  CAS  Google Scholar 

  89. Kaikaus RM, Chan WK, Lysenko N, et al: Induction of liver fatty acid binding protein (L-FABP) and peroxisomal fatty acid ω-oxidation by peroxisome proliferators (PP) is dependent on cytochrome p-450 activity. Hepatology 12:A248, 1990.

    Google Scholar 

  90. Hasumura Y, Teschke R, Lieber CS: Acetaldehyde oxidation by hepatic mitochondria: Its decrease after chronic ethanol consumption. Science 189:727–729, 1975.

    PubMed  CAS  Google Scholar 

  91. Korsten MA, Matsuzaki S, Feinman L, et al: High blood acetaldehyde levels after ethanol administration: Differences between alcoholic and non-alcoholic subjects. N Engl J Med 292:386–389, 1975.

    Article  PubMed  CAS  Google Scholar 

  92. Lieber CS, Baraona E, Hernandez-Munoz R, et al: Impaired oxygen utilization: A new mechanism for the hepatotoxicity of ethanol in sub-human primates. J Clin Invest 83:1682–1690, 1989.

    PubMed  CAS  Google Scholar 

  93. Pikkarainen PH, Gordon ER, Lebsack ME, et al: Determination of plasma free acetaldehyde levels during the oxidation of ethanol: Effects of chronic ethanol feeding. Biochem Pharmacol 30:799–802, 1981.

    Article  PubMed  CAS  Google Scholar 

  94. Espina N, Lima V, Lieber CS, et al: In vitro and in vivo inhibitory effect of ethanol and acetaldehyde on O6methylguanine transferase. Carcinogenesis 9:761–766, 1988.

    PubMed  CAS  Google Scholar 

  95. Arai M, Leo MA, Nakano M, et al: Biochemical and morphological alterations of baboon hepatic mitochondria after chronic ethanol consumption. Hepatology 4:165–174, 1984.

    PubMed  CAS  Google Scholar 

  96. Baraona E, Leo MA, Borowsky SA, et al: Pathogenesis of alcohol-induced accumulation of protein in the liver. J Clin lnvest 60:546–554, 1977.

    CAS  Google Scholar 

  97. Wondergem R, Davis J: Ethanol increases hepatocyte water volume. Alcohol Clin Exp Res 18:1230–1236, 1994.

    PubMed  CAS  Google Scholar 

  98. Israel Y, Hurwitz E, Niemela O, et al: Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts. Proc Natl Acad Sci USA 83:7923–7927, 1986.

    PubMed  CAS  Google Scholar 

  99. Hoerner M, Behrens UJ, Worner T, et al: Humoral immune response to acetaldehyde adducts in alcoholic patients. Res Commun Chem Pathol Pharmacol 54:3–12, 1986.

    PubMed  CAS  Google Scholar 

  100. Hoerner M, Behrens UJ, Worner TM, et al: The role of alcoholism and liver disease in the appearance of serum antibodies against acetaldehyde adducts. Hepatology 8:569–574, 1988.

    PubMed  CAS  Google Scholar 

  101. Niemela O, Klajner F, Orrego H, et al: Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. Hepatology 7:1210–1214, 1987.

    PubMed  CAS  Google Scholar 

  102. Muller A, Sies H: Inhibition of ethanol-and aldehyde-induced release of ethane from isolated perfused rat liver by pargyline and disulfiram. Pharmacol Biochem Behav 18:429–432, 1983.

    Article  PubMed  Google Scholar 

  103. Shaw S, Rubin KP, Lieber CS: Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease: Evidence of lipid peroxidation. Dig Dis Sci 28:585–589, 1983.

    Article  PubMed  CAS  Google Scholar 

  104. Speisky H, MacDonald A, Giles G, et al: Increased loss and decreased synthesis of hepatic glutathione after acute ethanol administration. Biochem J 225:565–572, 1985.

    PubMed  CAS  Google Scholar 

  105. Shaw S, Lieber CS: Increased hepatic production of alpha-amino-n-butyric acid after chronic alcohol consumption in rats and baboons. Gastroenterology 78108–113, 1980.

    PubMed  CAS  Google Scholar 

  106. Barclay LR The cooperative antioxidant role of glutathione with a lipid-soluble and a water-soluble antioxidant during peroxidation of liposomes initiated in the aqueous phase and in the lipid phase. JBiol Chem 263:16138–16142, 1988.

    CAS  Google Scholar 

  107. Shaw S, Jayatilleke E, Ross WA, et al: Ethanol induced lipid peroxidation: Potentiation by long-term alcohol feeding and attenuation by methionine. J Lab CIin Med 98:417–425, 1981.

    CAS  Google Scholar 

  108. Zhang H, Loney LA, Potter BJ: Effect of chronic alcohol feeding on hepatic iron status and ferritin uptake by rat hepatocytes. Alcohol Clin Exp Res 17:394–400, 1993.

    PubMed  CAS  Google Scholar 

  109. Valenzuela A, Femandez V, Videla LA: Hepatic and biliary levels of glutathione and lipid peroxides following iron overload in the rat: Effect of simultaneous ethanol administration. Toxicol Appl Pharmcol 7087–95, 1983.

    Article  CAS  Google Scholar 

  110. Tsukamoto H: Oxidative stress, antioxidants, and alcoholic liver fibrogenesis. Alcohol 10:465–467, 1993.

    PubMed  CAS  Google Scholar 

  111. Rankin JG: The natural history and management of the patient with alcoholic liver disease, in Fisher MM, Rankin JG (eds): Alcohol and the Liver. New York, Plenum Press, 1977, pp 365–381.

    Google Scholar 

  112. Morgan MY, Sherlock S: Sex-related differences among 100 patients with alcoholic liver disease. BrMedJ 1:939–941, 1977.

    CAS  Google Scholar 

  113. Pequignot G, Tuyns AJ, Berta JL: Ascitic cirrhosis in relation to alcohol consumption. Int J Epidemiol7:113–120, 1978.

    PubMed  CAS  Google Scholar 

  114. Parrish KM, Dufour MC, Stinson FS, et al: Average daily alcohol consumption during adult life among decedents with and without cirrhosis: The 1986 National Mortality Followback Survey. J Stud Alcohol 54:450–456, 1993.

    PubMed  CAS  Google Scholar 

  115. Fukunage T, Sillanaukee P, Eriksson CJP: Occurrence of blood acetaldehyde in women during ethanol intoxication: Preliminary findings. Alcohol Clin Exp Res 17:1198–1200, 1993.

    Google Scholar 

  116. Kato R, Yamazoe Y: Sex-specific cytochrome P450 as a cause of sex-and species-related differences in drug toxicity. Toxicol Lett 64/65:661–667, 1992.

    Article  Google Scholar 

  117. Ma XL, Baraona E, Lieber CS: Alcohol consumption enhances fatty acid ω-oxidation, with a greater increase in male than in female rats. Hepatology 18:1247–1253, 1993.

    Article  PubMed  CAS  Google Scholar 

  118. Pignon J-P, Bailey NC, Baraona E, et al: Fatty acid-binding protein: A major contributor to the ethanol-induced increase in liver cytosolic proteins in the rat. Hepatology 7:865–871, 1987.

    PubMed  CAS  Google Scholar 

  119. Shevchuk O, Baraona E, Ma X-L, et al: Gender differences in the response of hepatic fatty acids and cytosolic fatty acid-binding capacity to alcohol consumption in rats. Proc Soc Exp BiolMed 198:584–590, 1991.

    CAS  Google Scholar 

  120. Gomberg ESL: Women and alcohol: Use and abuse. J Nerv Ment Dis 181:211–219, 1993.

    PubMed  CAS  Google Scholar 

  121. Potter JF, James OFW: Clinical features and prognosis of alcoholic liver disease in respect of advancing age. Gerontology 33:380–387, 1987.

    PubMed  CAS  Google Scholar 

  122. Linnoila M, Erwin CW, Ramm D, et al: Effects of age and alcohol on psychomotor performance of men. J Stud Alcohol 41:488–541, 1980.

    PubMed  CAS  Google Scholar 

  123. Lumeng L, Crabb DW: Genetic aspects and risk factors in alcoholism and alcoholic liver disease. Gastroenterology 107:572–578, 1994.

    PubMed  CAS  Google Scholar 

  124. Kendler KS, Heath AC, Neale MC, et al: A population-based twin study of alcoholism in women. JAMA 268:1877–1882, 1992.

    Article  PubMed  CAS  Google Scholar 

  125. Blum K, Noble EP, Sheridan PJ, et al: Ailelic association of human dopamine D2 receptor gene in alcoholism. JAMA 263:2055–2060, 1990.

    PubMed  CAS  Google Scholar 

  126. Higuchi S, Muramatsu T, Murayama M, et al: Association of structural polymorphism of the dopamine D2 receptor gene and alcoholism. Biochem Biophys Res Commun 204:1199–1205, 1994.

    Article  PubMed  CAS  Google Scholar 

  127. Bolos AM, Dean M, Lucas-Derse S, et al: Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. JAMA 264:356–360, 1990.

    Article  Google Scholar 

  128. Gejman PV, Ram A, Gelernter J, et al: No structural mutation in the dopamine D, receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. JAMA 271:204–208, 1994.

    Article  PubMed  CAS  Google Scholar 

  129. Day CP, Bashir R, James O, et al: Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage. Hepatology 14:798–801, 1991.

    PubMed  CAS  Google Scholar 

  130. Poupon RE, Napalas B, Coutelle C, et al: Polymorphism of the alcohol dehydrogenase, alcohol and aldehyde dehydrogenase activities: Implications in alcoholic cirrhosis in white patients. Hepatology 15:1017–1022, 1992.

    PubMed  CAS  Google Scholar 

  131. Weiner FR, Eskreis D, Compton KV, et al: Haplotype analysis of type I collagen gene and its association with alcoholic cirrhosis in man. Mol Aspects Med 10:159–168, 1988.

    PubMed  CAS  Google Scholar 

  132. Bashir R, Day CP, James OFW, et al: No evidence for involvement of type I collagen structural genes in “genetic predisposition” to alcoholic cirrhosis. JHepatol 16:316–319, 1992.

    CAS  Google Scholar 

  133. Hrubec Z, Omenn GS: Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: Twin concordances for alcoholism and its biological end points by zygosity among male veterans. Alcohol Clin Exp Res 5:207–215, 1981.

    PubMed  CAS  Google Scholar 

  134. Savolainen VT, Pajarinen J, Perola M, et al: Glutathione-S-transferase GST M1 null genotype and the risk of alcoholic liver disease. Alcohol Clin Exp Res 20:1340–1345, 1996.

    PubMed  CAS  Google Scholar 

  135. Lieber CS, DeCarli LM: Hepatotoxicity of ethanol. JHepatol 12:394–401, 1991.

    CAS  Google Scholar 

  136. Lane BP, Lieber CS: Ultrastructural alterations in human hepatocytes following ingestion of ethanol with adequate diets. Am J Pathol 49:593–603, 1966.

    PubMed  CAS  Google Scholar 

  137. Lieber CS, DeCarli LM: An experimental model of alcohol feeding and liver injury in the baboon. J Med Primatol 3:153–163, 1974.

    PubMed  CAS  Google Scholar 

  138. Lieber CS, DeCarli LM, Rubin E: Sequential production of fatty liver, hepatitis and cirrhosis in sub-human primates fed ethanol with adequate diets. Proc Natl Acad Sci USA 72:437–441, 1975.

    PubMed  CAS  Google Scholar 

  139. Lieber CS: Perspectives: Do alcohol calories count? Am J Clin Nutr 54:976–982, 1991.

    PubMed  CAS  Google Scholar 

  140. Womer TM, Lieber CS: Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 254:627–630, 1985.

    Google Scholar 

  141. Hasumura Y, Minato Y, Nishimura M, et al: Hepatic fibrosis in alcoholics: Morphologic characteristics, clinical diagnosis, and natural course. Pathobiol Hepatic Fibrosis 7:23–24, 1985.

    Google Scholar 

  142. Popper H, Lieber CS: Histogenesis of alcoholic fibrosis and cirrhosis in the baboon. Am J Pathol 98:695–716, 1980.

    PubMed  CAS  Google Scholar 

  143. Lieber CS, DeCarli LM, Mak KM, et al: Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin. Hepatology 12:1390–1398, 1990.

    PubMed  CAS  Google Scholar 

  144. Lieber CS, Robins SJ, Li J, et al: Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 106:152–159, 1994.

    PubMed  CAS  Google Scholar 

  145. Lieber CS, Robins SJ, Leo MA: Hepatic phosphatidylethanolamine methyltransferase activity is decreased by ethanol and increased by phosphatidylcholine. Alcohol Clin Exp Res 18:592–595, 1994.

    PubMed  CAS  Google Scholar 

  146. Mak KI, Lieber CS: Lipocytes and transitional cells in alcoholic liver disease: A morpho-metric study. Hepatology 8:1027–1033, 1988.

    PubMed  CAS  Google Scholar 

  147. Friedman SL: The cellular basis of hepatic fibrosis. N Engl J Med 328:1828–1835, 1993.

    Article  PubMed  CAS  Google Scholar 

  148. Moshage H, Casini A, Lieber CS: Acetaldehyde stimulates collagen production in culturedrat liver fat-storing cells but not in hepatocytes. Hepatology 12:511–518, 1990.

    PubMed  CAS  Google Scholar 

  149. Casini A, Cunningham M, Rojkind M, et al: Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 13:758–765, 1991.

    Article  PubMed  CAS  Google Scholar 

  150. Yamada S, Mak KM, Lieber CS: Chronic ethanol consumption alters rat liver plasma membranes and potentiates release of alkaline phosphatase. Gastroenterology 88:1799–1806, 1985.

    PubMed  CAS  Google Scholar 

  151. Arai M, Leo MA, Nakano M, et al: Biochemical and morphological alterations of baboon hepatic mitochondria after chronic ethanol consumption. Hepatology 4:165–174, 1984.

    PubMed  CAS  Google Scholar 

  152. Arai M, Gordon ER, Lieber CS: Decreased cytochrome oxidase activity in hepatic mitochondria after chronic ethanol consumption and the possible role of decreased cytochrome aa3 content and changes in phospholipids. Biochim Biophys Acta 797:320–327, 1984.

    PubMed  CAS  Google Scholar 

  153. Navder KP, Baraona E, Lieber CS: Polyenylphosphatidylcholine attenuates alcohol-induced fatty liver and hyperlipemia in rats. J Nutr 21:1057–1062, 1997.

    Google Scholar 

  154. Li J-J, Kim C-I, Leo MA, et al: Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by stimulating collagenase activity in cultured lipocytes. Hepatology 15:373–381, 1992.

    PubMed  CAS  Google Scholar 

  155. Li J-J, Rosman AS, Leo MA, et al: Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis. Hepatology 19:1418–1423, 1994.

    Article  PubMed  CAS  Google Scholar 

  156. McClain C, Hill D, Schmidt J, et al: Cytokines and alcoholic liver disease. Semin Liver Dis 13:170–182, 1993.

    PubMed  CAS  Google Scholar 

  157. Paronetto F: Immunologic reactions in alcoholic liver disease. Semin Liver Dis 13:183–195, 1993.

    PubMed  CAS  Google Scholar 

  158. Rosman AS, Paronetto F, Galvin K, et al: Hepatitis C virus antibody in alcoholic patients: Association with the presence of portal and/or lobular hepatitis. Arch Intern Med 153:965–969, 1993.

    Article  PubMed  CAS  Google Scholar 

  159. Leo MA, Kim CI, Lowe N, et al: Interaction of ethanol with p-carotene: Delayed blood clearance and enhanced hepatotoxicity. Hepatology 15:883–891, 1992.

    PubMed  CAS  Google Scholar 

  160. Krinsky NI, Deneke SM: Interaction of oxygen and oxy-radicals with carotenoids. J Natl Cancer Inst 69:205–210, 1982.

    PubMed  CAS  Google Scholar 

  161. Krinsky NI: Antioxidant functions of carotenoids. Free Radic Biol Med 7:617–635, 1989.

    Article  PubMed  CAS  Google Scholar 

  162. Burton GW, Ingold KU: p-carotene: An unusual type of lipid antioxidant. Science 224:569–573, 1984.

    PubMed  CAS  Google Scholar 

  163. Halevy O, Sklan D: Inhibition of arachidonic acid oxidation by beta-carotene, retinol and alpha-tocopherol. Biochim Biophys Acta 918:304–307, 1987.

    PubMed  CAS  Google Scholar 

  164. Lomnitski L, Bar-Natan R, Sklan D, et al: The interaction between ß-carotene and lipoxy-genase in plant and animal systems. Biochim Biophys Acta 1167:331–338, 1993.

    PubMed  CAS  Google Scholar 

  165. Mobarhan S, Bowen P, Andersen B, et al: Effects of ß-carotene repletion of ß-carotene absorption, lipid peroxidation, and neutrophil superoxide formation in young men. Nutr Cancer 14:195–206, 1990.

    PubMed  CAS  Google Scholar 

  166. Alam SQ, Alam BS: Lipid peroxide, α-tocopherol and retinoid levels in plasma and liver of rats fed diets containing ß-carotene and 13-cis-retinoic acid. JNutr 113:2608–2614, 1983.

    CAS  Google Scholar 

  167. Jenkins MY, Sheikh MN, Mitchell GV, et al: Dietary carotenoids influenced biochemical but not morphological changes in adult male rats fed a choline-deficient diet. Nutr Cancer 19:55–65, 1993.

    Article  PubMed  CAS  Google Scholar 

  168. Kunert KJ, Tappel AL: The effect of vitamin C on in vitro lipid peroxidation in guinea pigs as measured by pentane and thane production. Lipids 18:271–274, 1983.

    PubMed  CAS  Google Scholar 

  169. Palozza P, Krinsky NI: The inhibition of radical-initiated peroxidation of microsomal lipids by both α-tocopherol and ß-carotene. FreeRadic Biol Med 11:407–414, 1991.

    CAS  Google Scholar 

  170. Kim-Jun H: Inhibitory effects of α-and ß-carotene on croton oil-induced or enzymatic lipid peroxidation and hydroperoxide production in mouse skin epidermis. Int J Biochem 25:911–915, 1993.

    Article  PubMed  CAS  Google Scholar 

  171. Ahmed S, Leo MA, Lieber CS: Interactions between alcohol and beta-carotene in patients with alcoholic liver disease. Am J Clin Nutr 60:430–436, 1994.

    PubMed  CAS  Google Scholar 

  172. Forman MR, Beecher GR, Lanza E, et al: Effect of alcohol consumption on plasma carotenoid concentrations in premenopausal women: A controlled dietary study. Am J Clin Nutr 62:131–135, 1995.

    PubMed  CAS  Google Scholar 

  173. Alpha-Tocopherol, β-Carotene and Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl JMed 330:1029–1035, 1994.

    Google Scholar 

  174. Albanes D, Heinonen OP, Taylor PR, et al: α-tocopherol and ß-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: Effects of base-line characteristics and study compliance J Natl Cancer Inst 88:1560–1571, 1996.

    PubMed  CAS  Google Scholar 

  175. Finkelstein JD, Martin JJ: Methionine metabolism in mammals. Adaptation to methionine excess. JBiolChem 261:1582–1587, 1986.

    CAS  Google Scholar 

  176. Horowitz JH, Rypins EB, Henderson JM, et al: Evidence for impairment of transsulfuration pathway in cirrhosis. Gastroenterology 81:668–675, 1981.

    PubMed  CAS  Google Scholar 

  177. Duce AM, Ortiz P, Cabrero C, et al: S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology 8:65–68, 1988.

    PubMed  CAS  Google Scholar 

  178. Lieber CS: Prevention and therapy with S-adenosyl-L-methionine and polyenylphos-phatidylcholine, in Arroyo V, Bosch J, Rodes J (eds): Treatments in Hepatology. Barcelona, Spain, Masson, 1995, pp 299–311.

    Google Scholar 

  179. Bjørneboe GEA, Bjørneboe A, Hagen BF, et al: Reduced hepatic tocopherol content after long-term administration of ethanol to rats. Biochem Biophys Acta 918:236–241, 1987.

    PubMed  Google Scholar 

  180. Kawase T, Kato S, Lieber CS: Lipid peroxidation and antioxidant defense systems in rat liver after chronic ethanol feeding. Hepatology 10:815–821, 1989.

    PubMed  CAS  Google Scholar 

  181. von Herbay A, de Groot H, Hegi U, et al: Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson’s disease. J Hepatol 20:41–46, 1994.

    Google Scholar 

  182. Pia de la Maza M, Petermann M, Bunout D, et al: Effects of long-term vitamin E supplementation in alcoholic cirrhotics. J Am Coll Nutr 14:192–196, 1995.

    Google Scholar 

  183. Seitz HK, Poschl G: Antioxidant drugs and colchicine in the treatment of alcoholic liver disease, in Arroyo V, Bosch J, Rodes J (eds): Treatments in Hepatology. Barcelona, Spain, Masson, 1995, pp 271–276.

    Google Scholar 

  184. Lieber CS, Leo MA, Aleynik SI, et al: Polyenylphosphatidylcholine (PPC) decreases oxidant stress and protects against alcohol-induced liver injury in the baboon. Hepatology 22:A225A 1995.

    Google Scholar 

  185. Aleynik SI, Leo MA, Ma X, et al: Polyenylphosphatidylcholine prevents carbon tetrachloride induced lipid peroxidation while it attenuates liver injury and fibrosis. JHepatology 26:554–561, 1997.

    Google Scholar 

  186. Takeshige U, Leo MA, Aleynik M, et al: Dilinoleoylphosphatidylcholine protects against lipid peroxidation and cell injury produced by arachidonate in hepatoma cells. Hepatology 24:A240 1996.

    Google Scholar 

  187. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine, 2nd ed. Oxford, England, Clarendon Press, 1989.

    Google Scholar 

  188. Parfitt VJ, Desomeaux K, Bolton CH, et al: Effects of high monounsaturated and polyunsatu-rated fat diets on plasma lipoproteins and lipid peroxidation in type 2 diabetes mellitus. DiabetMed 11:85–91, 1994.

    CAS  Google Scholar 

  189. Sosenko IRS, Innis SM, Frank L: Polyunsaturated fatty acids and protection of newborn rats from oxygen toxicity. JPediatr 112:630–637, 1988.

    CAS  Google Scholar 

  190. Sosenko IRS, Innis SM, Frank L: Menhaden fish oil, n-3 polyunsaturated fatty acids and protection of newborn rats from oxygen toxicity. Pediatr Res 25:399–404, 1989.

    PubMed  CAS  Google Scholar 

  191. Sosenko IRS, Innis SM, Frank L: Intralipid increases lung polyunsaturated fatty acids and protects newborn rats from oxygen toxicity. Pediatr Res 30:413–417, 1991.

    PubMed  CAS  Google Scholar 

  192. Dennery PA, Kramer CM, Alpert SE: Effect of fatty acid profiles on the susceptibility of cultured rabbit tracheal epithelial cells to hyperoxic injury. Am J Respir Cell Mol Biol 3:137–144, 1990.

    PubMed  CAS  Google Scholar 

  193. Spitz DR, Kinter MT, Kehrer JP, et al: The effect of monounsaturated and polyunsaturated fatty acids on oxygen toxicity in cultured cells. Pediatr Res 32:366–372, 1992.

    PubMed  CAS  Google Scholar 

  194. Lieber CS, Leo MA, Aleynik SI, et al: Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon. Alcohol Clin Exp Res 21:375–379, 1997.

    PubMed  CAS  Google Scholar 

  195. Ha YL, Storkson J, Pariza MW: Inhibition of benzo(a)pyrene-induced mouse forestomach neoplasia by conjugated dienoic derivatives of linoleic acid. Cancer Res 50:1097–1101, 1990.

    PubMed  CAS  Google Scholar 

  196. Ip C, Carter CA, Ip MM: Requirement of essential fatty acid for mammary tumorigenesis in the rat. Cancer Res 45:1997–2001, 1985.

    PubMed  CAS  Google Scholar 

  197. Helman RA, Temko MH, Nye SW, et al: Alcoholic hepatitis: Natural history and evaluation of prednisolone therapy. Ann Intern Med 74:311–321, 1971.

    PubMed  CAS  Google Scholar 

  198. Lesesne HR, Bozymski EM, Fallon JH: Liver physiology and disease: Treatment of alcoholic hepatitis with encephalopathy-comparison of prednisolone with caloric supplements. Gas-troenterology 74:169–173, 1978.

    CAS  Google Scholar 

  199. Maddrey WC, Boitnott JK, Bedine MS, et al: Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75: 193–199, 1978.

    PubMed  CAS  Google Scholar 

  200. Carithers RL Jr, Herlong FH, Diehl AM, et al: Methylprednisone therapy in patients with severe alcoholic hepatitis. A randomized multicentre trial. Ann Intern Med 110:685–690, 1989.

    PubMed  Google Scholar 

  201. Ramond MJ, Paynard T, Rueff B: A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N EnglJ Med 326:507–512, 1992.

    CAS  Google Scholar 

  202. Mathurin P, Duchatelle V, Ramond MJ, et al: Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 110:1847–1853, 1996.

    Article  PubMed  CAS  Google Scholar 

  203. Mendenhall CL, Moritz TE, Roselle GA, et al: A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: Results of a Department of Veterans Affairs Cooperative Study. Hepatology 17:564–576, 1993.

    PubMed  CAS  Google Scholar 

  204. Lieber CS, Leo MA, Mak KM, et al: Choline fails to prevent liver fibrosis in ethanol-fed baboons but causes toxicity. Hepatology 5:561–572, 1985.

    PubMed  CAS  Google Scholar 

  205. Sundler R, Akesson B: Regulation of phospholipid biosynthesis in isolated rat hepatocytes. J Biol Chem 250:3359–3367, 1975.

    PubMed  CAS  Google Scholar 

  206. Fox JM: Polyene phosphatidylcholine: Pharmacokinetics after oral administration-a review, in Avogaro P, Macini M, Ricci G, Paoletti R (eds): Phospholipids and atherosclerosis. New York, Raven Press, 1983, pp 65–80.

    Google Scholar 

  207. Zierenberg O, Grundy SM: Intestinal absorption of polyenylphosphatidylcholine in man. J LipidRes 23:1136–1142, 1982.

    CAS  Google Scholar 

  208. Parthasarathy S, Subbaiah PV, Ganguly J: The mechanism of intestinal absorption of phosphatidylcholine in rats. Biochem J 140:503–508, 1974.

    PubMed  CAS  Google Scholar 

  209. Rodgers JB, O’Brien RJ, Balint JA: The absorption and subsequent utilization of lecithin by the rat jejunum. Am J Dig Dis 20:208–211, 1975.

    PubMed  CAS  Google Scholar 

  210. Lekim D, Betzing H: The incorporation of essential phospholipids into the organs of intact and galactosamine intoxicated rats. Drug Res 24:1217–1221, 1974.

    CAS  Google Scholar 

  211. Arnesjo B, Nilsson Å, Barrowman J, et al: Intestinal digestion and absorption of cholesterol and lecithin in the human: Intubation studies with a fat-soluble reference substance. Scand J Gastroenterol 4:653–656, 1969.

    Article  PubMed  CAS  Google Scholar 

  212. Nilsson BE: Conditions contributing to fracture of the femoral neck. Acta Chir Scand 136:338–384, 1970.

    Google Scholar 

  213. Patton GM, Clark SB, Fasulo JM, et al: Utilization of individual lecithins in intestinal lipoprotein formation in the rat. J Clin Invest 73:231–240, 1984.

    PubMed  CAS  Google Scholar 

  214. Holz J, Wagner H: Uber den Einbau von intraduodenal appliziertem 14C/32-P-Poly-enephosphatidylcholin in die Leber von Ratten und seine Ausscheidung durch die Galle. Z Naturforsch 26:1151–1158, 1971.

    Google Scholar 

  215. Lekim D, Betzing H, Stoffel W: Incorporation of complete phospholipid molecules in cellular membranes of rat liver after uptake from blood serum. Hoppe-Seyler’s Z Physiol Chem 353S:929–946, 1972.

    Google Scholar 

  216. Lekim D, Graf E: Tierexperimentelle Studien zur Pharmakokinetik der “essentiellen” Phospholipids (EPL). Arzneimittelforschung 26:1772–1782, 1976.

    PubMed  CAS  Google Scholar 

  217. Ma X, Svegliati-Baroni G, Poniachik J, et al: Collagen synthesis by liver stellate cells is released from its normal feedback regulation by acetaldehyde-induced modification of carbon-terminal propeptide of procollagen. Alcohol Clin Exp Res 21:1204–1211, 1997.

    PubMed  CAS  Google Scholar 

  218. Ma X, Zhao J, Lieber CS: Polyenylphosphatidylcholine attenuates non-alcoholic hepatitis fibrosis and accelerates its regression. JHepatol 24:604–613, 1996.

    CAS  Google Scholar 

  219. Ehrlich HP, Ross R, Bornstein P: Effects of antimicrotubular agents on the secretion of collagen. JCell Biol 62:390–405, 1974.

    CAS  Google Scholar 

  220. Kershenobich D, Uribe M, Suarez GI, et al: Treatment of cirrhosis with colchicine. A doubleblind randomized trial. Gastroenterology 77:532–536, 1979.

    PubMed  CAS  Google Scholar 

  221. Kershenobich D, Vargas F, Garcia-Tsao G, et al: Colchicine in the treatment of cirrhosis of the liver. N EnglJ Med 318:1709–1713, 1988.

    CAS  Google Scholar 

  222. Boyer LJ, Ransohoff FD: Is colchicine effective therapy for cirrhosis? N Engl J Med 318:1751–1752, 1988

    Article  PubMed  CAS  Google Scholar 

  223. Plevris JN, Hayes PC, Bouchier IAD: Ursodeoxycholic acid in the treatment of alcoholic liver disease. Eur J Gastroenterol Hepatol 3:653–656, 1991.

    Google Scholar 

  224. Ferenci P, Dragosics B, Dittrich H, et al: Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 9:105–113, 1989.

    Article  PubMed  CAS  Google Scholar 

  225. Trinchet JC, Coste T, Levy VG, et al: Treatment of alcoholic hepatitis with silymarin: A double-blind comparative study in 116 patients. Gastroenterol Clin Biol 13:120–124, 1989.

    PubMed  CAS  Google Scholar 

  226. Keiding S, Badsberg JH, Becker U, et al: The prognosis of patients with alcoholic liver disease. An international randomized, placebo-controlled trial on the effect of malotilate on survival. J Hepatol 20:454–460, 1994.

    Article  PubMed  CAS  Google Scholar 

  227. Nanji AA, Khettry U, Sadradeh SMH, et al: Severity of liver injury in experimental alcoholic liver disease: Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am JPathol 142:367–373, 1993.

    CAS  Google Scholar 

  228. Shibayama Y, Asaka S, Nakata K: Endotoxin hepatotoxicity augmented by ethanol. Exp Mol Pathol 55:196–301, 1991.

    PubMed  CAS  Google Scholar 

  229. Khoruts A, Stahnke L, McClain CJ, et al: Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13:267–276, 1991.

    Article  PubMed  CAS  Google Scholar 

  230. Sheron N, Bird G, Goka J, et al: Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clin Exp lmmunol 84:449–453, 1991.

    CAS  Google Scholar 

  231. Czaja MJ, Xu J, Alt E: Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology 108:1849–1954, 1995.

    PubMed  CAS  Google Scholar 

  232. Mahler KM, Torrance DS, Smith CA, et al: Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 151:1548–1561, 1993.

    Google Scholar 

  233. Fisher CJ, Agosti JM, Opal SME, et al: Treatment of septic shock with the tumor necrosis factor receptor: Fc Fusion protein. N Engl J Med 334:1697–1702, 1996.

    Article  PubMed  CAS  Google Scholar 

  234. Brenner A, Alcom J: Therapy for hepatic fibrosis. Semin Liver Dis 10:75–83, 1990.

    PubMed  CAS  Google Scholar 

  235. Mezey E: Treatment of alcoholic liver disease. Semin Liver Dis 13:210–216, 1993.

    PubMed  CAS  Google Scholar 

  236. Kumar S, Stauber RE, Gavaler JS, et al: Orthotopic liver transplantation for alcoholic liver disease. Hepatology 11:159–164, 1990.

    PubMed  CAS  Google Scholar 

  237. Rosman AS, Lieber CS: Biochemical markers of alcohol consumption. Alcohol Health Res World 14:210–218, 1990.

    Google Scholar 

  238. Litten R, Allen J: Measuring Alcohol Consumption; Psychosocial and Biochemical Methods. Totowa, NJ, Humana, 1992.

    Google Scholar 

  239. Stibler H, Borg S, Joustra M: Microanion exchange chromatography of carbohydrate-deficient transferrin in serum in relation to alcohol consumption (Swedish Patent 8400587-5). Alcohol Clin Exp Res 10:535–544, 1986.

    PubMed  CAS  Google Scholar 

  240. Behrens, LJJ, Womer TM, Braly LF, et al: Carbohydrate-deficient transferrin (CDT), a marker for chronic alcohol consumption in different ethnic populations. Alcohol Clin Exp Res 12:427–432, 1988.

    PubMed  CAS  Google Scholar 

  241. Sörensen TIA, Orholm M, Bentsen KD, et al: Prospective evaluation of alcohol abuse and alcoholic liver injury in man as predictors of development of cirrhosis. Lancet 2:241–244, 1984.

    PubMed  Google Scholar 

  242. Nakano M, Worner T, Lieber CS: Perivenular fibrosis in alcoholic liver injury: Ultrastructure of histologic progression. Gastroenterology 83:777–785, 1982.

    PubMed  CAS  Google Scholar 

  243. Worner TM, Lieber CS: Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 254:627–630, 1985.

    Article  PubMed  CAS  Google Scholar 

  244. Mak KM, Leo MA, Lieber CS: Alcoholic liver injury in baboons: Transformation of lipocytes to transitional cells. Gastroenterology 87:188–200, 1984.

    PubMed  CAS  Google Scholar 

  245. Lieber CS: Pathogenesis and treatment of liver fibrosis: 1997 update. Dig Dis 15:42–66, 1997.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine and Pathology, Mount Sinai School of Medicine, New York, New York

    Charles S. Lieber

  2. Alcohol Dependence Treatment Program and Section of Liver Disease and Nutrition, Bronx VA Medical Center, Bronx, New York, 10468

    Charles S. Lieber

  3. Department of Medicine, Mount Sinai School of Medicine, New York, New York

    Maria A. Leo

  4. Bronx VA Medical Center, Bronx, New York, 10468

    Maria A. Leo

Authors
  1. Charles S. Lieber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria A. Leo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Kluwer Academic Publishers

About this chapter

Cite this chapter

Lieber, C.S., Leo, M.A. (1998). Metabolism of Ethanol and Some Associated Adverse Effects on the Liver and the Stomach. In: Recent Developments in Alcoholism. Recent Developments in Alcoholism, vol 14. Springer, Boston, MA. https://doi.org/10.1007/0-306-47148-5_2

Download citation

  • DOI: https://doi.org/10.1007/0-306-47148-5_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-45747-0

  • Online ISBN: 978-0-306-47148-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation